Community Perception and Attitude towards COVID-19 Vaccination for Children in Saudi Arabia
Abstract
:1. Introduction
2. Material and Methods
2.1. Study Design & Duration
2.2. Population, Inclusion and Exclusion Criteria and Sample Size
2.3. Data Collection Tool
Strongly Disagree | Disagree | Neutral | Agree | Strongly Agree | |
Item | 1 | 2 | 3 | 4 | 5 |
2.4. Data Analysis
3. Results
Participants Characteristics
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Saudi Arabia Situation. Available online: https://COVID19.who.int/region/emro/country/sa (accessed on 25 July 2022).
- Hussein, H.I.; Chams, N.; Chams, S.; El Sayegh, S.; Badran, R.; Raad, M.; Gerges-Geagea, A.; Leone, A.; Jurjus, A. Vaccines Through Centuries: Major Cornerstones of Global Health. Front. Public Health 2015, 3, 269. [Google Scholar] [CrossRef] [PubMed]
- Ehreth, J. The value of vaccination: A global perspective. Vaccine 2003, 21, 4105–4117. [Google Scholar] [CrossRef] [PubMed]
- Rodrigues, C.M.C.; Plotkin, S.A. Impact of Vaccines; Health, Economic and Social Perspectives. Front. Microbiol. 2020, 11, 1526. [Google Scholar] [CrossRef]
- Wu, F.; Zhao, S.; Yu, B.; Chen, Y.-M.; Wang, W.; Song, Z.-G.; Hu, Y.; Tao, Z.-W.; Tian, J.-H.; Pei, Y.-Y.; et al. A new coronavirus associated with human respiratory disease in China. Nature 2020, 579, 265–269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cucinotta, D.; Vanelli, M. WHO Declares COVID-19 a Pandemic. Acta Bio Med. Atenei Parm. 2020, 91, 157–160. [Google Scholar]
- Coustasse, A.; Kimble, C.; Maxik, K. COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome. J. Ambul. Care Manag. 2021, 44, 71–75. [Google Scholar] [CrossRef] [PubMed]
- The COVID-19 Vaccine Race—Weekly Update. Available online: https://www.gavi.org/vaccineswork/COVID-19-vaccine-Race (accessed on 9 April 2022).
- COVID-19 Vaccine Tracker. Available online: https://COVID19.trackvaccines.org/country/saudi-arabia/ (accessed on 9 April 2022).
- Saudi Ministry of Health. COVID-19 and Vaccine. 2022. Available online: https://www.moh.gov.sa/en/Ministry/HotTopics/Pages/COVID-19-Vaccine.aspx (accessed on 25 November 2022).
- World Health Organization. Ten Threats to Global Health in 2019. 2019. Available online: https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019 (accessed on 25 November 2022).
- MacDonald, N.E. SAGE Working Group on Vaccine Hesitancy Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine 2015, 33, 4161–4164. Available online: http://www.ncbi.nlm.nih.gov/pubmed/25896383 (accessed on 25 November 2022). [CrossRef]
- Alaamri, O.; Okmi, E.A.; Suliman, Y. Vaccine Hesitancy in Saudi Arabia: A Cross-Sectional Study. Trop. Med. Infect. Dis. 2022, 7, 60. [Google Scholar] [CrossRef]
- Alsubaie, S.S.; Gosadi, I.M.; Alsaadi, B.M.; Albacker, N.B.; Bawazir, M.A.; Bin-Daud, N.; Almanie, W.B.; Alsaadi, M.M.; Alzamil, F.A. Vaccine hesitancy among Saudi parents and its determinants. Result from the WHO SAGE working group on vaccine hesitancy survey tool. Saudi Med. J. 2019, 40, 1242–1250. [Google Scholar] [CrossRef]
- Jain, V.; Yuan, J.M. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: A systematic review and meta-analysis. Int. J. Public Health 2020, 65, 533–546. [Google Scholar] [CrossRef]
- Biharie, A.; Keuning, M.W.; Wolthers, K.C.; Pajkrt, D. Comorbidities, clinical characteristics and outcomes of COVID-19 in pediatric patients in a tertiary medical center in The Netherlands. World J. Pediatr. 2022, 18, 558–563. [Google Scholar] [CrossRef] [PubMed]
- Tsai, R.; Hervey, J.; Hoffman, K.; Wood, J.; Johnson, J.; Deighton, D.; Clermont, D.; Loew, B.; Goldberg, S.L. COVID-19 Vaccine Hesitancy and Acceptance among Individuals with Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey. JMIR Public Health Surveill. 2022, 8, e29872. [Google Scholar] [CrossRef] [PubMed]
- OpenEpi. Sample Size for X-Sectional, Cohort, and Clinical Trials. Available online: https://www.openepi.com/SampleSize/SSCohort.htm (accessed on 3 March 2022).
- Liu, Y.; Ma, Q.; Liu, H.; Guo, Z. Public attitudes and influencing factors toward COVID-19 vaccination for adolescents/children: A scoping review. Public Health 2022, 205, 169–181. [Google Scholar] [CrossRef] [PubMed]
- Anderson, E.J.; Campbell, J.D.; Creech, C.B.; Frenck, R.; Kamidani, S.; Munoz, F.M.; Nachman, S.; Spearman, P. Warp speed for COVID-19 vaccines: Why are children stuck in neutral? Clin. Infect. Dis. 2020, 73, 336–340. [Google Scholar] [CrossRef] [PubMed]
- Altulaihi, B.A.; Alabood, T.; Alharbi, K.G.; Alajmi, M.S.; Alkanhal, H.; Alshehri, A. Perception of Parents Towards COVID-19 Vaccine for Children in Saudi Population. Cureus 2021, 13, e18342. [Google Scholar] [CrossRef] [PubMed]
- Adella, G.A.; Abebe, K.; Atnafu, N.; Azeze, G.A.; Alene, T.; Molla, S.; Ambaw, G.; Amera, T.; Yosef, A.; Eshetu, K.; et al. Knowledge, attitude, and intention to accept COVID-19 vaccine among patients with chronic diseases in southern Ethiopia: Multi-center study. Front. Public Health 2022, 10, 917925. [Google Scholar] [CrossRef] [PubMed]
- Alwafi, H.; Naser, A.Y.; Aldhahir, A.M.; Alhazmi, A.; Alosaimi, A.N.; Mandili, R.A.; Majeed, Z.; Salawati, E.; Ekram, R.; Samannodi, M.; et al. COVID-19 vaccination side effects among the child age group: A large cross-sectional online based survey in Saudi Arabia. BMC Infect. Dis. 2022, 22, 911. [Google Scholar] [CrossRef]
- Khatatbeh, M.; Albalas, S.; Khatatbeh, H.; Momani, W.; Melhem, O.; Al Omari, O.; Tarhini, Z.; A’aqoulah, A.; Al-Jubouri, M.; Nashwan, A.J.; et al. Children’s rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: A multi-country study from the Eastern Mediterranean Region. BMC Public Health 2022, 22, 1375. [Google Scholar] [CrossRef]
- Alhazza, S.F.; Altalhi, A.M.; Alamri, K.M.; Alenazi, S.S.; Alqarni, B.A.; Almohaya, A.M. Parents’ Hesitancy to Vaccinate Their Children Against COVID-19, a Country-Wide Survey. Front. Public Health 2022, 10, 755073. [Google Scholar] [CrossRef]
- Ennaceur, S.; Al-Mohaithef, M. Parents’ Willingness to Vaccinate Children Against COVID-19 in Saudi Arabia: A Cross-329 Sectional Study. Vaccines 2022, 10, 156. [Google Scholar] [CrossRef]
- Shati, A.A.; Al-Qahtani, S.M.; Alsabaani, A.A.; Mahmood, S.E.; Alqahtani, Y.A.; AlQahtani, K.M.; Aldarami, M.S.; AlAmri, F.D.; Alqahtani, A.S.; AlHadi, A.M.; et al. Perceptions of Parents towards COVID-19 Vaccination in Children, Aseer Region, Southwestern Saudi Arabia. Vaccines 2022, 10, 1222. [Google Scholar] [CrossRef]
- Aedh, A.I. Parents’Attitudes, Their Acceptance of the COVID-19 Vaccines for Children and the Contributing Factors in Najran, Saudi Arabia: A Cross-Sectional Survey. Vaccines 2022, 10, 1264. [Google Scholar] [CrossRef]
- Almalki, O.S.; Alfayez, O.M.; Al Yami, M.S.; Asiri, Y.A.; Almohammed, O.A. Parents’ Hesitancy to Vaccinate Their 5–11-Year-Old Children against COVID-19 in Saudi Arabia: Predictors from the Health Belief Model. Front. Public Health 2022, 10, 842862. [Google Scholar] [CrossRef] [PubMed]
- Ünlütabak, B.; Velioğlu, İ. Examining children’s questions and parents’ responses about COVID-19 pandemic in Turkey. Curr. Psychol. 2022, 1–15. [Google Scholar] [CrossRef]
- Scherer, A.M.; Gidengil, C.A.; Gedlinske, A.M.; Parker, A.M.; Askelson, N.M.; Woodworth, K.R.; Petersen, C.A.; Lindley, M.C. COVID-19 Vaccination Intentions, Concerns, and Facilitators among US Parents of Children Ages 6 Months through 4 Years. JAMA Netw. Open 2022, 5, e2227437. [Google Scholar] [CrossRef] [PubMed]
- Fisher, C.B.; Bragard, E.; Jaber, R.; Gray, A. COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States. Vaccines 2022, 10, 1313. [Google Scholar] [CrossRef] [PubMed]
- Dubé, E.; MacDonald, N.E. COVID-19 vaccine hesitancy. Nat. Rev. Nephrol. 2022, 18, 409–410. [Google Scholar] [CrossRef]
Variables | No. | Percentage |
---|---|---|
Gender | ||
Male | 355 | 57.2 |
Female | 265 | 42.8 |
Age (years) | ||
18–25 | 211 | 34.0 |
26–35 | 186 | 30.0 |
36–40 | 67 | 10.8 |
41–45 | 62 | 10.0 |
46–50 | 46 | 7.4 |
>50 | 48 | 7.8 |
Geographical location | ||
Riyadh | 164 | 26.5 |
Asir | 116 | 18.7 |
Makkah | 105 | 16.9 |
Eastern Region | 60 | 9.7 |
Medina | 31 | 5.0 |
Jazan | 28 | 4.5 |
Najran | 26 | 4.2 |
Tabuk | 21 | 3.4 |
Qassim | 19 | 3.1 |
Al Baha | 16 | 2.6 |
Northern borders | 13 | 2.1 |
Hail | 11 | 1.8 |
Al Jouf | 10 | 1.6 |
Education | ||
Not educated | 14 | 2.3 |
Elementary | 23 | 3.7 |
Middle school | 25 | 4.1 |
High school | 149 | 24.0 |
Diploma | 49 | 7.9 |
College Graduate | 323 | 52.0 |
Master | 27 | 4.3 |
PhD | 10 | 1.7 |
Occupation | ||
Teacher | 59 | 9.6 |
Engineer | 21 | 3.4 |
Healthcare worker | 37 | 5.9 |
Government employee | 46 | 7.4 |
Private employee | 27 | 4.3 |
An employee in a commercial private sector | 38 | 6.1 |
Unemployed | 116 | 18.8 |
Businessman | 10 | 1.6 |
Other | 266 | 42.9 |
Monthly household income | ||
<5000 | 112 | 18.0 |
5000–10,000 | 133 | 21.5 |
11,000–15,000 | 169 | 27.3 |
16,000–20,000 | 112 | 18.0 |
21,000–25,000 | 52 | 8.4 |
>25,000 | 42 | 6.8 |
Marital status | ||
Single | 252 | 40.6 |
Married | 329 | 53.1 |
Divorced | 31 | 5.0 |
Widow | 8 | 1.3 |
Living status | ||
With family | 534 | 86.1 |
Alone | 86 | 13.9 |
Variables | No. | Percentage |
---|---|---|
Comorbidities among sample | ||
Yes | 106 | 17.1 |
No | 514 | 82.9 |
COVID-19 infection | ||
Yes | 178 | 28.7 |
No | 442 | 71.3 |
COVID-19 vaccination history | ||
Yes | 586 | 94.7 |
No | 33 | 5.3 |
1st dose | 134 | 22.8 |
2nd dose | 452 | 77.2 |
Concerns about COVID-19 disease for own self or family | ||
Yes | 351 | 56.6 |
No | 269 | 43.4 |
COVID-19 infection among participants’ families or relatives | ||
Yes | 436 | 70.3 |
No | 184 | 29.7 |
Loss of a family member or relative due to infection with COVID-19 | ||
Yes | 125 | 20.1 |
No | 495 | 79.9 |
Planning to take the second dose | ||
Yes | 106 | 79.1 |
No | 28 | 20.9 |
Third dose of the vaccine | ||
I won’t get it | 286 | 46.2 |
I will get it | 334 | 53.8 |
Demographics Variables | Categories | Children Vaccination | p-Value | |
---|---|---|---|---|
Opposers | Vaccine Supporter | |||
n (%) | n (%) | |||
Age | 18–25 | 50 (23.6) | 161 (76.4) | 0.688 |
26–35 | 54(29.0) | 132 (71.0) | ||
36–40 | 15(22.4) | 52 (77.6) | ||
41–45 | 16 (25.8) | 46 (74.2) | ||
46–50 | 9 (19.6) | 37 (80.4) | ||
>50 | 11 (22.9) | 37 (77.1) | ||
Gender | Male | 80 (22.5) | 275 (77.5) | 0.124 |
Female | 74 (27.9) | 191 (72.1) | ||
Geographic Location | Riyadh | 47 (28.7) | 117 (71.3) | 0.533 |
Qassim | 4 (21.1) | 15 (78.9) | ||
Eastern Region | 11 (18.3 | 49 (81.7) | ||
Makkah | 23 (21.9) | 82 (78.1) | ||
Medina | 7 (22.6) | 24 (77.4) | ||
Hail | 1 (9.1) | 10 (90.9) | ||
Al Jouf | 2 (20.0) | 8 (80.0) | ||
Tabuk | 3 (14.3) | 18 (85.7) | ||
Northern borders | 5 (38.5) | 8 (61.5) | ||
Asir | 33 (28.4) | 83 (71.6) | ||
Jazan | 7 (25.0) | 21 (75.0) | ||
Najran | 4 (15.4) | 22 (84.6) | ||
Al Baha | 6 (37.5) | 10 (62.5) | ||
Education | Not educated | 3 (21.4) | 11 (78.6) | 0.897 |
Elementary | 7 (30.4) | 16 (69.6) | ||
Middle school | 9 (36.0) | 16 (64.0) | ||
High school | 37 (24.8) | 112 (75.2) | ||
Diploma | 11 (22.4) | 38 (77.6) | ||
College graduate | 76 (23.5) | 247 (76.5) | ||
Master | 7 (25.9) | 20 (74.1) | ||
PhD | 3 (30.0) | 7 (70.0) | ||
Occupation | Teacher | 16 (27.1) | 43 (72.9) | 0.054 |
Engineer | 3 (14.3) | 18 (85.7) | ||
Health care worker | 6 (16.2) | 31 (83.8) | ||
Government employee | 9 (19.6) | 37 (80.4) | ||
Private employee | 7 (25.9) | 20 (74.1) | ||
Employee in a commercial private sector | 12 (31.6) | 26 (68.4) | ||
Unemployed | 40 (34.5) | 76 (65.5) | ||
Businessman | - | 10 (100.0) | ||
other | 63 (23.6) | 203 (76.4) | ||
Monthly household income | <5000 | 35 (31.3) | 77 (68.8) | 0.183 |
5000–10,000 | 32 (24.1) | 101 (75.9) | ||
11,000–15,000 | 48 (28.4) | 121 (71.6) | ||
16,000–20,000 | 21 (21.4) | 77 (78.6) | ||
20,001 and above | 20 (17.8) | 92 (82.2) | ||
Marital status | Single | 55 (21.9) | 197 (78.1) | 0.059 |
Married | 85 (25.8) | 244 (74.2) | ||
Divorced | 7 (22.6) | 24 (77.4) | ||
Widow | 5 (62.5) | 3 (37.5) | ||
Living status | With family | 136 (25.4%) | 398 (74.6%) | 0.255 |
Alone | 17 (19.8%) | 69 (80.2%) |
Factors | Categories | Children Vaccination | p-Value | |
---|---|---|---|---|
Opposers | Vaccine Supporter | |||
n (%) | n (%) | |||
Co-morbidities | Yes | 24(22.6) | 82 (77.4) | 0.593 |
No | 129 (25.1) | 385 (74.9) | ||
Previous COVID-19 infection | Yes | 39 (21.9) | 139 (78.1) | 0.310 |
No | 114 (25.8) | 328 (74.2) | ||
COVID-19 Vaccination history | 1st dose | 39 (29.1) | 95 (70.9) | <0.001 ** |
2nd dose | 92 (20.4) | 360 (79.6) | ||
Not vaccinated | 20 (60.6) | 13 (39.4) |
Attitudes Items | Categories | Children Vaccination | p-Value | |
---|---|---|---|---|
Opposers | Vaccine Supporter | |||
n (%) | n (%) | |||
Vaccination can prevent COVID-19 | Strongly agree | 3 (12.0) | 22(88.0) | |
Agree | 45 (13.0) | 302 (87.0) | <0.001 ** | |
Neither | 24 (25.5) | 70 (74.5) | ||
Disagree | 52 (44.4) | 65 (55.6) | ||
Strongly disagree | 17 (45.9) | 20 (54.1) | ||
The vaccine can prevent me from being a spreader | Strongly agree | 2 (8.0) | 23(92.0) | |
Agree | 33 (13.9) | 204 (86.1) | <0.001 ** | |
Neither | 38 (20.7) | 146 (79.3) | ||
Disagree | 50 (36.2) | 88 (63.8) | ||
Strongly disagree | 16 (44.4) | 20 (55.6) | ||
Relying on faith alone without any action to prevent infection. | Strongly agree | 28 (51.9) | 26 (48.1) | <0.001 ** |
Agree | 18 (40.0) | 27 (60.0) | ||
Neither | 23 (33.3) | 46 (66.7) | ||
Disagree | 49 (20.7) | 188 (79.0) | ||
Strongly disagree | 34 (15.8) | 181 (84.2) | ||
Social media has a role in increasing misconceptions and incorrect information about the vaccine. | Strongly agree | 42(29.2) | 102(70.8) | 0.519 |
Agree | 24(22.6) | 82(77.4) | ||
Neither | 20(26.7) | 55(73.3) | ||
Disagree | 29(20.6) | 112(79.4) | ||
Strongly disagree | 37(24.0) | 117(76.0) | ||
I think COVID-19 is not dangerous to my health | Strongly agree | 13(26.5) | 36(73.5) | <0.001 ** |
Agree | 32(41.6) | 45(58.4) | ||
Neither | 30(28.0) | 77(72.0) | ||
Disagree | 39(19.5) | 160(80.5) | ||
Strongly disagree | 36(19.1) | 152(80.9) |
Variables | OR | 95% CI | |
---|---|---|---|
Marital Status | Married (ref.) | 1 | |
Un married | 113.17 | 17.84–65.55 | |
Employment Status | Employed (ref.) | 1 | |
Un Employed | 19.14 | 0.109–0.43 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alalmaei Asiri, W.M.; Shati, A.A.; Mahmood, S.E.; Al-Qahtani, S.M.; Alqahtani, Y.A.; Alhussain, R.M.; Alshehri, N.A. Community Perception and Attitude towards COVID-19 Vaccination for Children in Saudi Arabia. Vaccines 2023, 11, 250. https://doi.org/10.3390/vaccines11020250
Alalmaei Asiri WM, Shati AA, Mahmood SE, Al-Qahtani SM, Alqahtani YA, Alhussain RM, Alshehri NA. Community Perception and Attitude towards COVID-19 Vaccination for Children in Saudi Arabia. Vaccines. 2023; 11(2):250. https://doi.org/10.3390/vaccines11020250
Chicago/Turabian StyleAlalmaei Asiri, Waddah M., Ayed A. Shati, Syed E. Mahmood, Saleh M. Al-Qahtani, Youssef A. Alqahtani, Raghad M. Alhussain, and Noura A. Alshehri. 2023. "Community Perception and Attitude towards COVID-19 Vaccination for Children in Saudi Arabia" Vaccines 11, no. 2: 250. https://doi.org/10.3390/vaccines11020250
APA StyleAlalmaei Asiri, W. M., Shati, A. A., Mahmood, S. E., Al-Qahtani, S. M., Alqahtani, Y. A., Alhussain, R. M., & Alshehri, N. A. (2023). Community Perception and Attitude towards COVID-19 Vaccination for Children in Saudi Arabia. Vaccines, 11(2), 250. https://doi.org/10.3390/vaccines11020250